Supply Chain
-
mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A
1/29/2024
During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.
-
Overcoming Cryopreservation Challenges
11/13/2023
In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich share how they are tackling some of the biggest issues in cryopreservation as well as best practices given the complex structure of freezing and thawing systems.
-
Perfusion: Planning A Run
6/16/2025
Learn about a logical approach for defining the operation of a perfusion run. We will break down the process using the three following steps: knowledge space, design space, and control space.
-
Thermo Fisher Scientific Single-Use Global Manufacturing Network
4/18/2022
We have implemented a multi-tier strategy to improve the resiliency of our supply chain and created the largest networked single-use manufacturing organization in the world.
-
Storing Your Banks With Ease And Confidence
2/17/2023
Discover a biorepository that will fulfill your need of long-term and short-term storage. You can never be too careful with your cell or virus banks. Explore three global sites that will ensure the safety of your bank.
-
Supporting The Global Biopharma Industry With Single-Use Capacity Expansion
4/22/2022
Explore Cytiva’s brand new single-use production facility in Wales, UK. This facility forms part of Cytiva’s >$1.5 billion investment in increased capacity to support the growing needs of the biopharmaceutical industry and to increase regional supply.
-
Comparing Manual Vs. Automated Processing And Thawing Systems
4/15/2025
In this segment of our Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists Pratik Jaluria, Ph.D., SVP Technical Development Strategy at BlueRock Therapeutics, Bruno Marques, Ph.D. VP, Process and Product Development at Century Therapeutics, and Kate Rochlin, Ph.D., COO at IN8bio share that a well-constructed manual operation can be matched by an automated system, but there is a higher capital expenditure.
-
Regulatory Considerations For An Optimized Cold Chain
11/13/2023
Here, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich detail some of the cold chain for cell therapies is beholden to regulatory requirements.
-
Risk Mitigation Strategies
11/13/2023
In this segment, Umoja's Co-Founder and CTO Ryan Crisman and BMS’ Global Head, Cell Therapy Logistics and Shipping Systems, Rookie Gleich explain some of the key risk management mitigation issues regarding managing temperature before, during, and after transit.
-
Supply Chain And Operational Challenges Facing mRNA
1/29/2024
Explore some of the biggest supply chain challenges facing mRNA cancer therapeutics and what short-term solutions may exist, starting with Chain of Custody/Chain of Identity.